You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. Long Pulse Laser Treatment of Psoriasis

    SBC: CANDELA CORPORATION            Topic: N/A

    The investigators will study the efficacy of long pulsed laser treatment for psoriasis. Psoriasis iwhich is often chronic in nature. Current treatment modalities do not result in a cure of this chroninvestigators wish to develop a safe and efficacious dye laser for psoriasis. The laser radiation wiselective absorption by erythrocytes in the capillaries of the dermal papillae. Subsequent thermal nm ...

    SBIR Phase I 1995 Department of Health and Human Services
  2. Picosecond Laser for Dermatology Applications

    SBC: CANDELA CORPORATION            Topic: N/A

    Analysis of the characteristic interaction time for laser tissue irradiation suggests that picosecopulses will operate in a temporal regime where photomechanical effects are dominant. At least in thethis mechanism is expected to lead to an improved treatment. To access this new laser treatment regimust be developed. Current picosecond laser systems of energy in excess of 1 mJ are complex and costo ...

    SBIR Phase I 1995 Department of Health and Human Services
  3. GENETICALLY ENGINEERED STREPTAVIDINS

    SBC: CAPTEC, LLC            Topic: N/A

    N/A

    STTR Phase I 1998 Department of Health and Human Services
  4. Bridge Amplification for Blood Banking Tests

    SBC: CBR LABORATORIES, INC.            Topic: N/A

    The long term objective of this project is to develop a novel diagnostic testing methodology that csafety and volume of the blood supply. The basis for this method is an innovative amplification techBRIDGE allows for the simultaneous detection of a plurality of organisms or cellular antigens in a ssimplicity and sensitivity of BRIDGE will allow more extensive screening while reducing the overall(c ...

    SBIR Phase I 1995 Department of Health and Human Services
  5. Novel Inhibitor of Hageman Factor

    SBC: CBR LABORATORIES, INC.            Topic: N/A

    We will investigate the ability of a novel human endothelial cell derived protein to ameliorate advbiomaterials in contact with blood. This protein (HEDA) has recently been purified from human endothand has been found to inhibit activation of Hageman factor (factor XII) by glass. Factor XII activatactivation of coagulation, fibrinolysis, complement and kinin pathways. These pathways are importanth ...

    SBIR Phase I 1995 Department of Health and Human Services
  6. PEPTIDE INHIBITORS OF NFAT ACTIVATION BY CALCINEURIN

    SBC: CBR LABORATORIES, INC.            Topic: N/A

    N/A

    SBIR Phase I 1998 Department of Health and Human Services
  7. RAPID DETECTION OF PRE AND NEONATAL METABOLIC DISORDERS

    SBC: CC Technology            Topic: N/A

    N/A

    SBIR Phase I 1998 Department of Health and Human Services
  8. Continuous Flow Centrifugal Membrane Separator

    SBC: Centracept, Inc.            Topic: N/A

    Current centrifugation and filtration methodologies in the bioprocess separation train cause probleproduct loss due to contamination, degradation, equipment fouling, and high shear force induced cellamplify downstream fouling of expensive purification equipment and processes, ultimately resulting idegradation and contamination. Typically, centrifugation equipment requires significant expendituresm ...

    SBIR Phase I 1995 Department of Health and Human Services
  9. HORMONE PULSATILITY DIFFERENCES VIA COARSE TIME-SAMPLING

    SBC: Steven M. Pincus            Topic: N/A

    N/A

    SBIR Phase I 1998 Department of Health and Human Services
  10. NOVEL ASSAY FOR G PROTEIN COUPLED RECEPTORS

    SBC: CIENCIA INC            Topic: N/A

    N/A

    SBIR Phase I 1998 Department of Health and Human Services
US Flag An Official Website of the United States Government